ME Group International plc (FRA:PHQ)

Intra-Cellular Therapies Income Statement

Financials in millions GBP. Fiscal year is November - October.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 30, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Revenue	311.32	307.89	297.66	259.78	214.4	206.83
Revenue Growth (YoY)	2.34%	3.44%	14.58%	21.16%	3.66%	-3.97%
Cost of Revenue	196.43	198.54	195.77	178.22	178.54	169.07
Gross Profit	114.89	109.34	101.9	81.56	35.87	37.76
Selling, General & Admin	35.77	32.96	31.41	31.45	28.99	31.53
Other Operating Expenses	-0.2	-0.21	-0.19	-0.6	-0.32	-0.61
Operating Expenses	37.35	34.63	32.66	31.68	28.67	30.92
Operating Income	77.54	74.72	69.24	49.87	7.2	6.84
Interest Expense	-2.54	-2.61	-2.42	-2.15	-2.95	-1.73
Interest & Investment Income	-	0.67	1.4	-	0.1	0.04
Earnings From Equity Investments	0	0	0.01	-	-	-
Currency Exchange Gain (Loss)	0.31	0.31	-0.96	-0.36	-	-
Other Non Operating Income (Expenses)	-0.21	-0.19	0.53	-0.72	26.6	-0.28
EBT Excluding Unusual Items	75.1	72.9	67.8	46.65	30.95	4.87
Impairment of Goodwill	-1.01	-1.01	-0.7	-	-	-
Gain (Loss) on Sale of Investments	0.25	-	-	-	-	0.09
Gain (Loss) on Sale of Assets	1.63	0.04	0.06	6.86	1.09	-
Asset Writedown	0.38	0.38	-0.09	-0.15	-3.49	-4.63
Other Unusual Items	1.12	1.12	-	-	-	-
Pretax Income	77.47	73.42	67.07	53.35	28.56	0.33
Income Tax Expense	20.41	19.33	16.4	14.56	6.7	1.9
Earnings From Continuing Operations	57.06	54.09	50.67	38.79	21.85	-1.57
Minority Interest in Earnings	-	-	-	-	-0.14	0.03
Net Income	57.06	54.09	50.67	38.79	21.71	-1.54
Net Income to Common	57.06	54.09	50.67	38.79	21.71	-1.54
Net Income Growth	7.85%	6.76%	30.61%	78.66%	-	-
Shares Outstanding (Basic)	377	377	378	378	378	378
Shares Outstanding (Diluted)	380	379	381	379	379	378
Shares Change (YoY)	0.09%	-0.38%	0.40%	0.04%	0.32%	-0.07%
EPS (Basic)	0.15	0.14	0.13	0.10	0.06	-0.00
EPS (Diluted)	0.15	0.14	0.13	0.10	0.06	-0.00
EPS Growth	7.81%	7.21%	30.11%	78.10%	-	-
Free Cash Flow	38.84	35.06	37.49	46.01	27.49	27.36
Free Cash Flow Per Share	0.10	0.09	0.10	0.12	0.07	0.07
Dividend Per Share	0.083	0.079	0.074	0.056	0.029	-
Dividend Growth	5.46%	6.90%	31.96%	93.77%	-	-
Gross Margin	36.90%	35.51%	34.23%	31.39%	16.73%	18.26%
Operating Margin	24.91%	24.27%	23.26%	19.20%	3.36%	3.31%
Profit Margin	18.33%	17.57%	17.02%	14.93%	10.13%	-0.74%
Free Cash Flow Margin	12.47%	11.39%	12.59%	17.71%	12.82%	13.23%
EBITDA	107.55	105.52	100.14	79.08	36.04	34.5
EBITDA Margin	34.55%	34.27%	33.64%	30.44%	16.81%	16.68%
D&A For EBITDA	30.02	30.8	30.9	29.21	28.85	27.65
EBIT	77.54	74.72	69.24	49.87	7.2	6.84
EBIT Margin	24.91%	24.27%	23.26%	19.20%	3.36%	3.31%
Effective Tax Rate	26.35%	26.33%	24.45%	27.29%	23.47%	578.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.